Intravitreal Fasudil Combined with Bevacizumab for Treatment of Refractory Diabetic Macular Edema; a Pilot Study

Intravitreal Fasudil Combined with Bevacizumab for Treatment of Refractory Diabetic Macular Edema; a Pilot Study

Purpose: To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB) on refractory diabetic macular edema (DME). Methods: This prospective, interventional ca...

Full description

Bibliographic Details
Main Authors: Ramin Nourinia, Hamid Ahmadieh, Mohammad-Hassan Shahheidari, Souska Zandi, Shintaro Nakao, Ali Hafezi-Moghadam
Format: Article
Language:English
Published: Knowledge E 2013-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Diabetic Macular Edema; Rho Kinase; Angiogenesis
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2013;volume=8;issue=4;spage=337;epage=340;aulast=Nourinia

Internet

http://www.jovr.org/article.asp?issn=2008-322X;year=2013;volume=8;issue=4;spage=337;epage=340;aulast=Nourinia

Similar Items